NOVO.B.DK

232.05

+0.69%↑

GMAB.DK

1,712

+1.15%↑

HLUNB.DK

40.04

+2.25%↑

ZEAL.DK

297.8

+2.37%↑

AMBUB.DK

68.1

+0.52%↑

NOVO.B.DK

232.05

+0.69%↑

GMAB.DK

1,712

+1.15%↑

HLUNB.DK

40.04

+2.25%↑

ZEAL.DK

297.8

+2.37%↑

AMBUB.DK

68.1

+0.52%↑

NOVO.B.DK

232.05

+0.69%↑

GMAB.DK

1,712

+1.15%↑

HLUNB.DK

40.04

+2.25%↑

ZEAL.DK

297.8

+2.37%↑

AMBUB.DK

68.1

+0.52%↑

NOVO.B.DK

232.05

+0.69%↑

GMAB.DK

1,712

+1.15%↑

HLUNB.DK

40.04

+2.25%↑

ZEAL.DK

297.8

+2.37%↑

AMBUB.DK

68.1

+0.52%↑

NOVO.B.DK

232.05

+0.69%↑

GMAB.DK

1,712

+1.15%↑

HLUNB.DK

40.04

+2.25%↑

ZEAL.DK

297.8

+2.37%↑

AMBUB.DK

68.1

+0.52%↑

Search

Coloplast A-S (Class B)

Fermé

437.1 0.14

Résumé

Variation du prix de l'action

24h

Actuel

Min

436.7

Max

443.6

Chiffres clés

By Trading Economics

Revenu

522M

1.4B

Ventes

83M

7B

P/E

Moyenne du Secteur

24.382

57.05

BPA

6.32

Rendement du dividende

5.47

Marge bénéficiaire

19.835

Employés

16,983

EBITDA

309M

2.3B

Recommandations

By TipRanks

Recommandations

Neutre

Prévisions sur 12 Mois

+11.86% upside

Dividendes

By Dow Jones

Rendement du dividende

Moyenne du Secteur

5.47%

2.52%

Prochains Résultats

12 mai 2026

Date du Prochain Dividende

20 mai 2026

Date du Prochain Détachement de Dividende

18 mai 2026

Statistiques du Marché

By TradingEconomics

Capitalisation Boursière

-21B

97B

Ouverture précédente

436.96

Clôture précédente

437.1

Coloplast A-S (Class B) Graphique

Les performances passées ne sont pas un indicateur fiable des résultats futurs.

Actualités Associées

30 mars 2026, 23:15 UTC

Principaux Événements d'Actualité

U.K. Shoppers Paid a Little More This Month But Worse May yet Lie Ahead

30 mars 2026, 22:36 UTC

Principaux Événements d'Actualité

Australian Government Rules Out Boots on the Ground in the Middle East

30 mars 2026, 22:13 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350 Million

30 mars 2026, 21:00 UTC

Résultats

Aktis Oncology Gets FDA Clearance for Phase 1 Billion Trial of Tumor Treatment

30 mars 2026, 20:15 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Developments Have Added Significant Economic Uncertainty

30 mars 2026, 23:40 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 23:40 UTC

Market Talk

Nikkei May Decline on Higher Energy Cost Concerns -- Market Talk

30 mars 2026, 23:36 UTC

Market Talk

Gold Edges Lower Amid Divergent Signals on U.S.-Iran Talks -- Market Talk

30 mars 2026, 23:12 UTC

Market Talk

Alcoa Earnings Outlook Boosted by Market Disruptions -- Market Talk

30 mars 2026, 22:49 UTC

Market Talk

Fed's Williams: Core Inflation Forecast Is Little Changed -- Market Talk

30 mars 2026, 22:44 UTC

Market Talk

Fed's Williams: Risks to Both Sides of Dual Mandate Higher -- Market Talk

30 mars 2026, 22:43 UTC

Market Talk

Fed's Williams Says Focus Is on Inflation Expectations Being Well Anchored -- Market Talk

30 mars 2026, 22:42 UTC

Market Talk

South32 Should Go for Growth, Says New Bull -- Market Talk

30 mars 2026, 22:18 UTC

Market Talk

Paragon Care's Chances of Using Levy to Pass on Higher Costs `Close to Zero' -- Market Talk

30 mars 2026, 22:05 UTC

Market Talk

Northern Star's New Bull Argues Case for Asset Sales -- Market Talk

30 mars 2026, 21:58 UTC

Acquisitions, Fusions, Rachats

Sun Life Financial Agrees to Buy Bell Partners for $350M

30 mars 2026, 21:39 UTC

Acquisitions, Fusions, Rachats

Sun Life Sees 1Q Charge to Net of C$236M From BGO, Crescent Deals

30 mars 2026, 21:38 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Remaining Equity Interest Purchases of BGO, Crescent Capital

30 mars 2026, 21:36 UTC

Acquisitions, Fusions, Rachats

Sun Life to Buy Fully Bell Partners for $350M >SLF.T

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Shareholders Expected to Own Two-Thirds of New Food Entity, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Deal to Create $60 Billion Food Giant With McCormick -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Could Be Announced As Soon As Tuesday, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Unilever Nears Cash-and-Stock Deal to Combine Food Business With McCormick, Sources Say -- WSJ

30 mars 2026, 21:33 UTC

Acquisitions, Fusions, Rachats

Deal Set to Value Combined Food Business At Around $60B Including Debt, Sources Say -- WSJ

30 mars 2026, 21:25 UTC

Market Talk

Global Forex and Fixed Income Roundup: Market Talk

30 mars 2026, 21:25 UTC

Market Talk

Warehouse Showing Cost Discipline But Margin Goal at Risk -- Market Talk

30 mars 2026, 21:03 UTC

Acquisitions, Fusions, Rachats

Sun Life: Completes Equity Interest Purchases of BGO and Crescent Cap, Announces Acquisition of Bell Partners, a Multifamily Real Estate Investment Manager

30 mars 2026, 20:50 UTC

Market Talk

Basic Materials Roundup: Market Talk

30 mars 2026, 20:09 UTC

Résultats

This Stock Looks Like a Solid AI Bet -- and Wall Street Hasn't Noticed Yet -- Barrons.com

30 mars 2026, 20:00 UTC

Principaux Événements d'Actualité

Fed's Williams: Middle-East Conflict 'Will Likely Boost Overall Inflation in Coming Months'

Comparaison

Variation de prix

Coloplast A-S (Class B) prévision

Objectif de Prix

By TipRanks

11.86% hausse

Prévisions sur 12 Mois

Moyen 901.38 DKK  11.86%

Haut 1,056 DKK

Bas 720 DKK

Basé sur 8 analystes de Wall Street proposant des objectifs de prix à 12 mois pour Microsoft Corp. au cours des 3 derniers mois.

Note du Consensus

By TipRanks

Neutre

8 ratings

2

Achat

4

Maintien

2

Vente

Éléments financiers

Frais Généraux et Administratifs

Dépenses d'exploitation

Résultat avant impôt

Ventes

Coût des ventes

Marge brute des ventes

Charges d'intérêt sur la dette

EBITDA

Bénéfice d'exploitation

$

À Propos Coloplast A-S (Class B)

Coloplast A/S engages in the development and sale of intimate healthcare products and services in Denmark, the United States, the United Kingdom, France, and internationally. The company operates through Chronic Care, Continence Care, Voice and Respiratory Care, Interventional Urology, and Advanced Wound Care segments. It provides ostomy care products, including SenSura Mio, which provides fit individual body shapes and optimal discretion for various types of ostomies; and SenSura Ostomy care solutions, as well as ostomy accessories under the Brava brand. The company also offers continence care products, such as Conveen Active urine bags; SpeediCath catheters that offer catheterization for both genders; and Peristeen Plus, a transanal irrigation system. In addition, it provides wound care products comprising conforming dressing under the Biatain Silicone brand and hydrocolloid dressing under the Comfeel brand; and skin care products that include cleansers, moisturizers, skin protectants, antifungal products, and hand cleansers, as well as InterDry, a skin fold management solution. Further, the company develops, produces, and markets products for the surgical treatment of urological and gynecological disorders, such as urinary stone diseases, benign prostate hyperplasia, voiding dysfunctions, erectile dysfunction, and urinary incontinence. Additionally, its voice and respiratory care solutions include laryngectomy care products comprising Provox, a voice prosthesis for speaking, HMEs, adhesives, laryngectomy tubes for breathing, devices for speaking hands-free, and accessories, as well as tracheostomy care products under Tracoe brand. Coloplast A/S was founded in 1954 and is headquartered in Humlebæk, Denmark.
help-icon Live chat